Boston Scientific Corporation

NYSE BSX · Marlborough, MA

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Boston Scientific Corporation is a clinical trial sponsor based in Marlborough, MA, listed as NYSE BSX. It has 71 active clinical trials with 76,795 planned participants, across 14 therapeutic areas. Since 2021 it has completed 203 trials and stopped 46 early. Its FDA record on file shows 5 recalls.

Trial track record · since 2021

71Active trials76,795 planned participants
203Completed177 with results posted
46Stopped early18% of finished trials

FDA record

0InspectionsNone posted since 2025
0Warning lettersNone on file
5RecallsLatest 2026-09-30: Class I

Recent FDA actions

Financials · NYSE BSX

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 71 active trials

StageTrialStatus

Questions about Boston Scientific Corporation

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Boston Scientific Corporation. Informational only.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.